TippingPoint Biosciences
Stub active Updated Apr 2, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
Founders
About
TippingPoint Biosciences is a drug discovery startup co-founded by Laura Hsieh, PhD, and chromatin biologist Geeta Narlikar, PhD, of UCSF 1. The company develops a platform targeting epigenetic protein interfaces previously considered “undruggable” by recreating disease-specific chromatin environments to reveal transient protein-protein interactions unique to pathological states 1. Their initial focus is Diffuse Intrinsic Pontine Glioma (DIPG), an aggressive pediatric brainstem tumor with no FDA-approved therapies 1. The company has 9 employees and is headquartered in San Francisco 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-03-31 | Seed | $4.5M | SOSV, LKS Fund | Sazze Partners, Freeflow Ventures, StoryHouse Ventures, Sontag Innovation Fund, American Cancer Society BrightEdge, XEIA, WeCAN 1 |
What Investors Say
No verified investor quotes available at this time.
What Founders Say
No verified founder quotes available at this time.